Larvol Delta - Disease-Course-Outcomes-and-Complications-in-Pregnant-and-Breastfeeding-Women-with-Multiple-Sclerosis-Treated-with-Rituximab-or-Ocrelizumab-A-Narrative-Review

Rituxan (rituximab) - Roche

Ocrevus (ocrelizumab) - Roche

http://www.ncbi.nlm.nih.gov/pubmed/42732421

Fereshteh Ashtari; Mahnaz Momenzadeh

Sep 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next